1986 |
Japan |
FEC-1 |
CTX-M-1 |
Escherichia coli from the fecal flora of laboratory dogs used for pharmacokinetic studies and previously administered cephem antibiotics |
Matsumoto et al. (1988) |
1989 |
Germany |
CTX-M-1 |
CTX-M-1 |
Escherichia coli isolate recovered from the ear of a 4-month child suffering from otitis media in Munich. The β-lactamases involved were firstly named as cefotaximases |
Bauernfeind et al. (1990) |
1989 |
Argentina |
CTX-M-2 |
CTX-M-2 |
Salmonella Thypimurium isolates from hospitalized patients with meningitis, septicemia, or enteritis |
Bauernfeind et al. (1992) |
1989 |
France |
MEN-1 |
CTX-M-1 |
Escherichia coli isolate in France in an Italian patient. Later sequencing reveals identity with CTX-M-1 |
Bernard et al. (1992), Barthélémy et al. (1992) |
1993 |
Japan |
Toho-1 |
CTX-M-2 |
Escherichia coli isolate recovered from a 1-year-old female child who developed cystitis. Toho-1 was later renamed as CTX-M-44 |
Ishii et al. (1995) |
1996 |
Poland |
CTX-M-3 |
CTX-M-1 |
Citrobacter freundii and Escherichia coli isolates recovered in Warsaw in patients with urinary tract infections |
Gniadkowski et al. (1998) |
1999 |
Taiwan |
CTX-M-3 |
CTX-M-1 |
Different Escherichia coli isolates from several sources in hospitalized and non-hospitalized patients |
Yan et al. (2000) |
1994 |
France |
CTX-M-9 |
CTX-M-9 |
A retrospective study showed presence of Escherichia coli with this enzyme in this country before its first recognition in Spain |
Saladin et al. (2002) |
1996 |
Spain |
CTX-M-9 |
CTX-M-9 |
First description of CTX-M-14 in an Escherichia coli isolate from a patients with an urinary tract infection |
Sabaté et al. (2000) |
1996 |
Brazil |
CTX-M-9 |
CTX-M-9 |
Escherichia coli isolate recovered from an hospitalized patient in Rio de Janeiro |
Bonnet et al. (2001) |
1997 |
China |
CTX-M-9 |
CTX-M-9 |
Escherichia coli and Klebsiella pneumoniae recovered as part of an antimicrobial resistance monitoring project |
Chanawong et al., 2002
|
1996 |
Korea |
CTX-M-14 |
CTX-M-9 |
Detected in Shigella sonnei and in blood isolates of Escherichia coli and Klebsiella pneumoniae
|
Pai et al. (2001) |
1997–1998 |
China |
CTX-M-14 |
CTX-M-9 |
Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae recovered as part of an antimicrobial resistance monitoring project |
Chanawong et al. (2002) |
1998 |
Taiwan |
CTX-M-14 |
CTX-M-9 |
Escherichia coli recovered during a multicenter antimicrobial resistance surveillance study |
Ma et al. (2002) |
1998 |
Poland |
CTX-M-15 |
CTX-M-1 |
A retrospective study showed the presence of Serratia marcescens and Escherichia coli before the first description of this enzyme in India. Sequence and plasmid analysis revealed potential evolution from CTX-M-3 |
Baraniak et al. (2002) |
1999 |
India |
CTX-M-15 |
CTX-M-1 |
First description of this enzyme |
Karim et al. (2001) |
2001 |
United Kingdom |
CTX-M-15 |
CTX-M-1 |
Spread in the community of Escherichia coli isolates with CTX-M-1. A major clone was later identified as belonging to the international 25:H4-ST131 clone |
Mushtaq et al. (2003), Woodford et al. (2004) |
1996–1997 |
Brazil |
CTX-M-8 |
CTX-M-8 |
Enterobacter cloacae, Citrobacter amalonaticus, and Enterobacter aerogenes from different sources in hospitalized patients |
Bonnet et al. (2000) |
2000 |
Canada |
CTX-M-25 |
CTX-M-25 |
Escherichia coli isolate recovered from an hospitalized patient |
Munday et al. (2004) |